Image Source: Unsplash
Buy a Small Cap Biotech Today
We saw many of our SMID Life Science stocks trade up big last week so we are tempted to be more aggressive adding speculative biotech positions. Last week we added CRSP to our longs and went into the volatile ETF the Ark Genomic Revolution (ARKG) based on holdings and previous technical action. We will also track potential new trades in 10X Genomics (TXG), Vericel (VCEL) and Caribou Biosciences (CRBU). But as you can see the damage was severe in 2023 because the market preferred MEGA-TECH stock in 2023.We also picked Becton Dickinson (BDX) up 2.9% last week to $258.91, FWD PE is 19.2, P/S 3.94, and Recommendation is 1.76. If you don’t want to pick risky biotech stocks then buy a core life science position with PRHSX or the IBB. PRHSX has among top holdings: UNH, TMO, REGN, LLY, MRK, etc.We have summarized below some of the Small and Mid Cap (SMID) life science stocks that we own and recorded the trades in a post on February 26,2023 when speculative small caps started sinking. So we have trimmed back most of them.Key Points to Consider:
We will update the trades on Wednesday.Selected Well Known SMID BIOtechs- a screen not a buy list.
More By This Author:Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield…
Healthcare Portfolio Focus Stocks